en

PRODUCT DETAIL

Erelzi 50 mg injekčný roztok v naplnenom pere

Code 4609C
MA number EU/1/17/1195/010
Product Form: sol inj 2x1 ml/50 mg (pero napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L04 Immunosuppressants
L04A Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-alpha) inhibitors
L04AB01 Etanercept
Shelf life: 36
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 23.06.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 29.04.2022
eu-flag.png sk-flag.png